150 related articles for article (PubMed ID: 3602028)
1. A dietary haloperidol regimen for inducing dopamine receptor supersensitivity in rats.
Frey JM; Morgan WW; Ticku MK; Huffman RD
Pharmacol Biochem Behav; 1987 Apr; 26(4):661-9. PubMed ID: 3602028
[TBL] [Abstract][Full Text] [Related]
2. Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rats.
Rupniak NM; Kilpatrick G; Hall MD; Jenner P; Marsden CD
Psychopharmacology (Berl); 1984; 84(4):512-9. PubMed ID: 6441952
[TBL] [Abstract][Full Text] [Related]
3. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity.
Staunton DA; Magistretti PJ; Shoemaker WJ; Deyo SN; Bloom FE
Brain Res; 1982 Jan; 232(2):401-12. PubMed ID: 6322915
[TBL] [Abstract][Full Text] [Related]
4. Effects of prolyl-leucyl-glycinamide and cyclo(leucyl-glycine) on the supersensitivity of dopamine receptors in brain induced by chronic administration of haloperidol to rats.
Bhargava HN
Neuropharmacology; 1984 Apr; 23(4):439-44. PubMed ID: 6145116
[TBL] [Abstract][Full Text] [Related]
5. The effects of chronic lithium on behavioral and biochemical indices of dopamine receptor supersensitivity in the rat.
Pittman KJ; Jakubovic A; Fibiger HC
Psychopharmacology (Berl); 1984; 82(4):371-7. PubMed ID: 6427831
[TBL] [Abstract][Full Text] [Related]
6. Long-term treatment with lithium prevents the development of dopamine receptor supersensitivity.
Pert A; Rosenblatt JE; Sivit C; Pert CB; Bunney WE
Science; 1978 Jul; 201(4351):171-3. PubMed ID: 566468
[TBL] [Abstract][Full Text] [Related]
7. Repeated administration of sulpiride for three weeks produces behavioural and biochemical evidence for cerebral dopamine receptor supersensitivity.
Jenner P; Hall MD; Murugaiah K; Rupniak N; Theodorou A; Marsden CD
Biochem Pharmacol; 1982 Feb; 31(3):325-8. PubMed ID: 7200363
[TBL] [Abstract][Full Text] [Related]
8. Behavioral and biochemical aspects of neuroleptic-induced dopaminergic supersensitivity: studies with chronic clozapine and haloperidol.
Seeger TF; Thal L; Gardner EL
Psychopharmacology (Berl); 1982; 76(2):182-7. PubMed ID: 6805029
[TBL] [Abstract][Full Text] [Related]
9. Chronic molindone treatment: relative inability to elicit dopamine receptor supersensitivity in rats.
Meller E
Psychopharmacology (Berl); 1982; 76(3):222-7. PubMed ID: 6808540
[TBL] [Abstract][Full Text] [Related]
10. Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not with increases in D-1 receptors.
Fleminger S; Rupniak NM; Hall MD; Jenner P; Marsden CD
Biochem Pharmacol; 1983 Oct; 32(19):2921-7. PubMed ID: 6138043
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of continuous administration for 1 year of haloperidol or sulpiride on striatal dopamine function in the rat.
Rupniak NM; Mann S; Hall MD; Fleminger S; Kilpatrick G; Jenner P; Marsden CD
Psychopharmacology (Berl); 1984; 84(4):503-11. PubMed ID: 6441951
[TBL] [Abstract][Full Text] [Related]
12. Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the rat.
Rupniak NM; Hall MD; Mann S; Fleminger S; Kilpatrick G; Jenner P; Marsden CD
Biochem Pharmacol; 1985 Aug; 34(15):2755-63. PubMed ID: 4040370
[TBL] [Abstract][Full Text] [Related]
13. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. I. Locomotor activity and behavioral supersensitivity.
Staunton DA; Magistretti PJ; Shoemaker WJ; Bloom FE
Brain Res; 1982 Jan; 232(2):391-400. PubMed ID: 6322914
[TBL] [Abstract][Full Text] [Related]
14. Hypophysectomy does not prevent development of striatal dopamine receptor supersensitivity induced by repeated neuroleptic treatment.
Jenner P; Rupniak NM; Hall MD; Dyer R; Leigh N; Marsden CD
Eur J Pharmacol; 1981 Nov; 76(1):31-6. PubMed ID: 6119220
[TBL] [Abstract][Full Text] [Related]
15. Chronic haloperidol treatment potentiates apomorphine- and ethanol-induced hypothermia in the rat.
Lai H; Kazi MS; Carino MA; Horita A
Life Sci; 1982 Mar; 30(10):821-6. PubMed ID: 7200179
[TBL] [Abstract][Full Text] [Related]
16. SCH 23390 may alter dopamine-mediated motor behaviour via striatal D-1 receptors.
Boyce S; Kelly E; Davis A; Fleminger S; Jenner P; Marsden CD
Biochem Pharmacol; 1985 May; 34(10):1665-9. PubMed ID: 2988552
[TBL] [Abstract][Full Text] [Related]
17. Differences in the time course of dopaminergic supersensitivity following chronic administration of haloperidol, molindone, or sulpiride.
Prosser ES; Pruthi R; Csernansky JG
Psychopharmacology (Berl); 1989; 99(1):109-16. PubMed ID: 2506596
[TBL] [Abstract][Full Text] [Related]
18. Amantadine reduces haloperidol-induced dopamine receptor hypersensitivity in the striatum.
Allen RM; Lane JD; Brauchi JT
Eur J Pharmacol; 1980 Jul; 65(2-3):313-5. PubMed ID: 7190503
[TBL] [Abstract][Full Text] [Related]
19. Enhanced striatal 3H-spiroperidol binding induced by chronic haloperidol treatment inhibited by peptides administered during the withdrawal phase.
Bhargava HN
Life Sci; 1984 Feb; 34(9):873-9. PubMed ID: 6142397
[TBL] [Abstract][Full Text] [Related]
20. 7-[3-(4-[2,3-Dimethylphenyl]piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392), a presynaptic dopamine autoreceptor agonist and postsynaptic D2 receptor antagonist.
Yasuda Y; Kikuchi T; Suzuki S; Tsutsui M; Yamada K; Hiyama T
Life Sci; 1988; 42(20):1941-54. PubMed ID: 3130534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
